202 related articles for article (PubMed ID: 21601318)
21. Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice.
Lorentzen AO; Sveberg L; Midtvedt Ø; Kerty E; Heuser K
Clin Neuropharmacol; 2014; 37(5):142-8. PubMed ID: 25229171
[TBL] [Abstract][Full Text] [Related]
22. Potential biomarkers of monocyte/macrophage activity in a patient with sarcoidosis, treated with infliximab.
Fang B; Bhagat S; Busch R; Parfrey H; Hall FC
Rheumatology (Oxford); 2011 May; 50(5):992-4. PubMed ID: 21278065
[No Abstract] [Full Text] [Related]
23. Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab.
Toth C; Martin L; Morrish W; Coutts S; Parney I
Acta Neurol Scand; 2007 Oct; 116(4):259-62. PubMed ID: 17824906
[TBL] [Abstract][Full Text] [Related]
24. Treatment of sarcoidosis with infliximab.
Doty JD; Mazur JE; Judson MA
Chest; 2005 Mar; 127(3):1064-71. PubMed ID: 15764796
[TBL] [Abstract][Full Text] [Related]
25. [Bilateral optic neuropathy revealing systemic sarcoidosis].
Guilpain P; Andreu MA; Cassoux N; Le Thi Huong-Boutin D; Jaeger-Bizet F; Nasica X; Chapelon-Abric C; Wechsler B; Lehoang P; Piette JC
Rev Med Interne; 2004 Oct; 25(10):755-8. PubMed ID: 15471602
[TBL] [Abstract][Full Text] [Related]
26. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.
Yee AM; Pochapin MB
Ann Intern Med; 2001 Jul; 135(1):27-31. PubMed ID: 11434729
[TBL] [Abstract][Full Text] [Related]
27. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review.
Massara A; Cavazzini L; La Corte R; Trotta F
Semin Arthritis Rheum; 2010 Feb; 39(4):313-9. PubMed ID: 19147181
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial.
Judson MA; Baughman RP; Costabel U; Flavin S; Lo KH; Kavuru MS; Drent M;
Eur Respir J; 2008 Jun; 31(6):1189-96. PubMed ID: 18256069
[TBL] [Abstract][Full Text] [Related]
29. Optic neuropathy in refractory neurosarcoidosis treated with TNF-alpha antagonist.
Salama B; Gicquel JJ; Lenoble P; Dighiero PL
Can J Ophthalmol; 2006 Dec; 41(6):766-8. PubMed ID: 17224962
[TBL] [Abstract][Full Text] [Related]
30. Sarcoid sacroiliitis: successful treatment with infliximab.
Agrawal S; Bhagat S; Dasgupta B
Ann Rheum Dis; 2009 Feb; 68(2):283. PubMed ID: 19139204
[No Abstract] [Full Text] [Related]
31. Infliximab or biosimilars in sarcoidosis; to switch or not to switch?
Veltkamp M; Drent M; Baughman RP
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan; 32(4):280-3. PubMed ID: 26847093
[No Abstract] [Full Text] [Related]
32. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
[TBL] [Abstract][Full Text] [Related]
33. Targeting the TNF-alpha pathway in sarcoidosis.
Antoniu SA
Expert Opin Ther Targets; 2010 Jan; 14(1):21-9. PubMed ID: 20001207
[TBL] [Abstract][Full Text] [Related]
34. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer?
Denys BG; Bogaerts Y; Coenegrachts KL; De Vriese AS
Clin Sci (Lond); 2007 Mar; 112(5):281-9. PubMed ID: 17261090
[TBL] [Abstract][Full Text] [Related]
35. Does tumour necrosis factor-alpha inhibitor infliximab induce histological resolution of pulmonary sarcoid granulomas?
Milman N; Andersen CB; Baslund B; Loft A; Iversen M
Clin Respir J; 2007 Dec; 1(2):106-13. PubMed ID: 20298289
[TBL] [Abstract][Full Text] [Related]
36. [Misdiagnosed childhood sarcoidosis as non-Langerhans' cell histiocytosis treated with tumor necrosis factors-α antagonists].
Petiti Martin G; Castellanos González M; Sanz Bueno J; Burgués Calderón M; Villar Buil M; Vanaclocha F; Peralto JL
An Pediatr (Barc); 2012 Oct; 77(4):267-71. PubMed ID: 22608978
[TBL] [Abstract][Full Text] [Related]
37. Infliximab therapy for sarcoidosis (lupus pernio).
Haley H; Cantrell W; Smith K
Br J Dermatol; 2004 Jan; 150(1):146-9. PubMed ID: 14746631
[TBL] [Abstract][Full Text] [Related]
38. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
Rosen T; Doherty C
Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
[TBL] [Abstract][Full Text] [Related]
39. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
Thielen AM; Barde C; Saurat JH; Laffitte E
Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
Sweiss NJ; Welsch MJ; Curran JJ; Ellman MH
Arthritis Rheum; 2005 Oct; 53(5):788-91. PubMed ID: 16208666
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
